Surgery Partners, Inc. SGRY
$13.11
-$0.25-1.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.75% | 4.50% | 2.38% | 6.63% | 8.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.75% | 4.50% | 2.38% | 6.63% | 8.41% |
| Cost of Revenue | 4.46% | 5.96% | 6.66% | 5.62% | 8.18% |
| Gross Profit | -2.76% | -1.05% | -9.16% | 10.03% | 9.15% |
| SG&A Expenses | 0.55% | 9.17% | -34.17% | -23.29% | -10.42% |
| Depreciation & Amortization | -2.48% | 6.06% | 76.70% | -21.31% | 15.80% |
| Other Operating Expenses | 9.52% | -- | 47.31% | 22.73% | 67.69% |
| Total Operating Expenses | 3.90% | 5.89% | 8.69% | 2.43% | 8.20% |
| Operating Income | -3.96% | -6.14% | -22.83% | 34.70% | 9.67% |
| Income Before Tax | -26.26% | -1,000.00% | -42.59% | 182.57% | 31.53% |
| Income Tax Expenses | 336.36% | -- | -88.74% | 22.22% | -122.45% |
| Earnings from Continuing Operations | -33.85% | -600.00% | 162.23% | 295.31% | 58.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.70% | 9.63% | 28.92% | -25.98% | -7.97% |
| Net Income | -500.00% | 4.77% | 86.18% | 28.39% | 83.87% |
| EBIT | -3.96% | -6.14% | -22.83% | 34.70% | 9.67% |
| EBITDA | -3.59% | -2.62% | -6.52% | 16.01% | 11.14% |
| EPS Basic | -490.86% | 6.08% | 86.37% | 28.94% | 83.97% |
| Normalized Basic EPS | -7.19% | -28.53% | -92.64% | -107.41% | -149.70% |
| EPS Diluted | -500.00% | 6.67% | 86.37% | 28.34% | 83.73% |
| Normalized Diluted EPS | -7.19% | -28.53% | -92.64% | -107.41% | -149.70% |
| Average Basic Shares Outstanding | 1.45% | 1.39% | 1.44% | 0.82% | 0.67% |
| Average Diluted Shares Outstanding | 1.45% | 1.39% | 1.44% | 0.82% | 0.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |